Growth Metrics

Inogen (INGN) Current Deferred Revenue (2016 - 2026)

Inogen has reported Current Deferred Revenue over the past 13 years, most recently at $5.5 million for Q4 2025.

  • Quarterly Current Deferred Revenue fell 17.3% to $5.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.5 million through Dec 2025, down 17.3% year-over-year, with the annual reading at $5.5 million for FY2025, 17.3% down from the prior year.
  • Current Deferred Revenue was $5.5 million for Q4 2025 at Inogen, down from $6.0 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $9.1 million in Q3 2022 and troughed at $5.5 million in Q4 2025.
  • The 5-year median for Current Deferred Revenue is $8.0 million (2021), against an average of $7.7 million.
  • Year-over-year, Current Deferred Revenue increased 27.1% in 2021 and then fell 17.63% in 2024.
  • A 5-year view of Current Deferred Revenue shows it stood at $8.6 million in 2021, then rose by 3.64% to $8.9 million in 2022, then dropped by 10.14% to $8.0 million in 2023, then fell by 16.62% to $6.7 million in 2024, then decreased by 17.3% to $5.5 million in 2025.
  • Per Business Quant, the three most recent readings for INGN's Current Deferred Revenue are $5.5 million (Q4 2025), $6.0 million (Q3 2025), and $6.3 million (Q2 2025).